Home WikiTelehealth
WikiTelehealth: the plain-English reference
Short, sourced entries on GLP-1 medicines, compounding, insurance and online care. Each one starts with a definition, cites its sources and shows when it was last checked.
Browse by category
Medications
Molecules and brand names: what each one is, who makes it and what it is approved for.
Concepts
How these medicines work, how doses are raised and the trials behind them.
Pharmacy & compounding
Who makes compounded medicines, under which rules, and how they differ from brand-name drugs.
Insurance & cost
Coverage, prior authorization, PBMs, formularies and paying with pre-tax money.
History & timeline
From Gila monster venom to daily pills: how GLP-1 medicines came to be.
Conditions
The conditions these treatments are prescribed for.
All entries A-Z
#
- 503A pharmacy
- A 503A pharmacy is a state-licensed pharmacy, or a licensed physician, that compounds medicines under section 503A of the Federal Food, Drug, and...
- 503B outsourcing facility
- A 503B outsourcing facility is a compounder that registers with the FDA under section 503B of the Federal Food, Drug, and Cosmetic Act and must...
B
- Body mass index (BMI)
- Body mass index (BMI) is a number calculated from a person's weight and height, used to screen adults for underweight, overweight and obesity.
C
- Compounded semaglutide
- Compounded semaglutide is semaglutide prepared by a state-licensed compounding pharmacy for an individual prescription, rather than made by the...
- Compounded tirzepatide
- Compounded tirzepatide is tirzepatide prepared by a state-licensed compounding pharmacy for an individual prescription, rather than made by the...
- Compounding pharmacy
- A compounding pharmacy is a pharmacy that prepares a medicine by combining, mixing or changing ingredients to fit the needs of an individual patient.
E
- ED medications (sildenafil and tadalafil)
- ED medications are prescription drugs that treat erectile dysfunction, and the most widely used are the PDE5 inhibitors sildenafil (Viagra) and...
- Erectile dysfunction
- Erectile dysfunction (ED) is a condition in which a man cannot get or keep an erection firm enough for sex.
- Exenatide and the Gila monster
- Exenatide, the first GLP-1 receptor agonist, is a lab-made copy of exendin-4, a peptide found in the venom of the Gila monster.
F
G
- GIP (glucose-dependent insulinotropic polypeptide)
- GIP (glucose-dependent insulinotropic polypeptide) is a hormone released by the upper small intestine after a meal that helps the pancreas release...
- GLP-1 drug shortage (2022-2025)
- The GLP-1 drug shortage was a period from 2022 to 2025 when the FDA listed semaglutide and tirzepatide injections on its national drug shortage...
- GLP-1 microdosing
- GLP-1 microdosing is the off-label practice of using a GLP-1 medicine at doses below the labeled starting dose, or at longer gaps between doses.
- GLP-1 receptor agonist
- A GLP-1 receptor agonist is a medicine that acts like glucagon-like peptide-1 (GLP-1), a hormone made in the gut after eating.
H
- HSA and FSA
- A health savings account (HSA) and a health flexible spending arrangement (FSA) are tax-favored accounts that people in the United States can use...
L
- Liraglutide
- Liraglutide is a once-daily injectable GLP-1 receptor agonist first made by Novo Nordisk, sold as Victoza for type 2 diabetes and as Saxenda for...
M
- Mounjaro
- Mounjaro is Eli Lilly's brand of tirzepatide for type 2 diabetes, approved by the FDA on May 13, 2022, as the first medicine that acts on both the...
N
- NAD+ (nicotinamide adenine dinucleotide)
- NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell that helps turn food into energy and supports DNA repair.
O
- Obesity
- Obesity is a chronic disease in which a person has excess body fat that can harm health, defined in adults as a body mass index (BMI) of 30 or...
- Orforglipron
- Orforglipron is a once-daily oral GLP-1 receptor agonist made by Eli Lilly and sold under the brand name Foundayo.
- Ozempic
- Ozempic is Novo Nordisk's brand of semaglutide for type 2 diabetes, first approved by the FDA as a once-weekly injection on December 5, 2017.
P
- Pharmacy benefit manager (PBM)
- A pharmacy benefit manager (PBM) is a company that runs prescription drug benefits for health plans and employers.
- Prior authorization
- Prior authorization is a process in which a health plan must approve a drug or service before it agrees to pay for it.
R
- Retatrutide
- Retatrutide is an investigational once-weekly injection from Eli Lilly that activates three hormone receptors: GIP, GLP-1 and glucagon.
- Rybelsus
- Rybelsus is Novo Nordisk's brand of oral semaglutide for type 2 diabetes, approved by the FDA on September 20, 2019, as the first GLP-1 medicine in...
S
- Semaglutide
- Semaglutide is a GLP-1 receptor agonist made by Novo Nordisk, sold as Ozempic and Rybelsus for type 2 diabetes and as Wegovy for chronic weight...
- Sermorelin
- Sermorelin is a lab-made peptide made of the first 29 amino acids of growth hormone-releasing hormone (GHRH), which signals the pituitary gland to...
- STEP trials
- The STEP trials (Semaglutide Treatment Effect in People with obesity) are the phase 3 clinical trials of once-weekly semaglutide 2.4 mg for weight...
- SURMOUNT trials
- The SURMOUNT trials are the phase 3 clinical trials of once-weekly tirzepatide for weight management run by Eli Lilly.
T
- Telehealth prescribing
- Telehealth prescribing is the practice of a licensed clinician evaluating a patient remotely, by video, phone or secure online forms, and then...
- Timeline of GLP-1 medicines
- The timeline of GLP-1 medicines runs from the discovery of the GLP-1 hormone in the early 1980s to the first approved GLP-1 drug, Byetta, in 2005...
- Tirzepatide
- Tirzepatide is a once-weekly injectable medicine made by Eli Lilly that activates both the GIP and GLP-1 receptors.
- Titration (dose escalation)
- Titration, or dose escalation, is the practice of starting a medicine at a low dose and raising it in steps until the maintenance dose is reached.
- Type 2 diabetes
- Type 2 diabetes is a chronic disease in which the body does not respond well to insulin, so blood sugar stays too high.
W
- Wegovy
- Wegovy is Novo Nordisk's brand of semaglutide for chronic weight management, first approved by the FDA as a once-weekly 2.4 mg injection on June 4,...
- Wegovy pill
- The Wegovy pill is a once-daily semaglutide tablet for chronic weight management, approved by the FDA on December 22, 2025, as the first GLP-1 pill...
Z
- Zepbound
- Zepbound is Eli Lilly's brand of tirzepatide for chronic weight management, approved by the FDA on November 8, 2023.